Expression dynamics of the REL, RELA, and IRF1 transcription factors in U937 macrophages after dioxin exposure

Expression dynamics of the REL, RELA, and IRF1 transcription factors in U937 macrophages after... The aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor, is involved in a wide range of critical cellular events in response to endogenous signals or xenobiotics. 2,3,7,8-Tetrachlorodibenzo-para-dioxin (TCDD) is one of the AhR ligands with the maximum affinity for AhR. TCDD is the most toxic among the dioxin xenobiotics and induces a wide range of biological responses, including immunotoxicity and cancer. The complex ligand:AhR:ARNT functions as a transcription factor, binding to the dioxin responsive element (DRE) sequences in the regulatory regions of target genes. Macrophages are key regulators of the innate immune response and being present in all body organs and tissues, they are one of the cell types that are the first to encounter xenobiotics; thus, the insight into the TCDD effect on macrophages is of paramount importance. Putative DREs are predicted using the SITECON software tool in the regulatory regions of the genes encoding transcription factors REL, RELA, and IRF1, expressed in macrophages. The nuclear extract and total RNA are isolated from the U937 macrophage-like cells exposed to 10 nM TCDD (or 0.1% DMSO as the control) for 1, 3, and 6 h. The binding of the TCDD:AhR:ARNT transcription complex from the nuclear extract with double-stranded oligonucleotides containing the putative DREs was studied by the EMSA. Quantitative real-time PCR demonstrates that the expression of these genes in the U937 macrophages increases in a statistically significant manner 1 h (the characteristic time of the maximal dioxin:AhR:ARNT translocation to the nucleus) after exposure to 10 nM TCDD. These results confirm the functional activity of the DREs residing in the IRF1, REL, and RELA regulatory regions via the AhR signaling pathway. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Russian Journal of Genetics: Applied Research Springer Journals

Expression dynamics of the REL, RELA, and IRF1 transcription factors in U937 macrophages after dioxin exposure

Loading next page...
 
/lp/springer_journal/expression-dynamics-of-the-rel-rela-and-irf1-transcription-factors-in-93nHcKWiiB
Publisher
Pleiades Publishing
Copyright
Copyright © 2017 by Pleiades Publishing, Ltd.
Subject
Biomedicine; Human Genetics
ISSN
2079-0597
eISSN
2079-0600
D.O.I.
10.1134/S2079059717050082
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial